Treatment with liraglutide may improve markers of CVD reflected by reduced levels of apoB.
Engelbrechtsen L, Lundgren J, Wewer Albrechtsen NJ, Mahendran Y, Iepsen EW, Finocchietto P, Jonsson AE, Madsbad S, Holst JJ, Vestergaard H, Hansen T, Torekov SS.
Engelbrechtsen L, et al.
Obes Sci Pract. 2017 Nov 21;3(4):425-433. doi: 10.1002/osp4.133. eCollection 2017 Dec.
Obes Sci Pract. 2017.
PMID: 29259801
Free PMC article.